

































1Journal of Cardiology Cases 9 (2014) 217–220
Contents lists available at www.sciencedirect.com
Journal  of  Cardiology  Cases
journa l h om epage: www.elsev ier .com/ locate / j ccase
ase  Report
cute  coronary  syndrome  in  a  patient  with  multifocal  coronary
asospasm
nês  Rangel  (MD) ∗,  Rui  Almeida  (MD),  Teresa  Pinho  (MD),  Carla  de  Sousa  (MD),
omingos Magalhães  (MD),  Maria  Júlia  Maciel  (MD,  PhD)
ardiology Department, Centro Hospitalar de S. João, Porto, Portugal
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 11 June 2013
eceived  in revised form 4 December 2013
ccepted 31 January 2014
a  b  s  t  r  a  c  t
Vasospastic  angina  results  from  temporary  spasm  of one  or more  coronary  segments.  Although  prognosis
of  patients  presenting  with  coronary  vasospasm  appears  to be generally  good,  multivessel  coronary





We  present  a  case  of  a 51-year-old  man  admitted  to the emergency  room  due  to severe  retrosternal
pain,  who  was  documented  with  multifocal  coronary  vasospasm.
<Learning objective:  The  case  described  illustrates  the  importance  of  recognizing  coronary  vasospasm
as  a cause  of reversible  ischemia.  Although  vasospastic  angina  is  associated  with  a  favorable  prognosis,
multivessel  involvement  may  increase  the  risk  of life-threatening  cardiac  events.>
©  2014  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.ntroduction
Vasospastic angina results from temporary spasm of one or more
oronary segments and it may  be associated with other vasomotor
isturbances, such as migraine or Raynaud’s phenomenon, suggest-
ng that it may  be part of a generalized vascular disorder.
Furthermore, coronary vasospasm and coronary atherosclerotic
isease often coexist and may  make a mutual contribution to dis-
ase progression [1,2].
Acute  coronary syndrome (ACS) patients with coronary spasm
enerally have a good prognosis [3]. However, spontaneous simul-
aneous multivessel coronary artery spasm is an uncommon ﬁnding
nd a major predictor of worse prognosis [4].
ase report
A 51-year-old obese, smoker, Caucasian man, with a medical
istory of severe migraine headache, was admitted to the emer-
ency room due to severe retrosternal pain, lasting 30 min, which
ad started in the early morning, at rest. He had a history of mod-
rate alcohol intake and denied illicit drug use. He had no history
f cardiovascular events and took no outpatient medication.
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ttp://dx.doi.org/10.1016/j.jccase.2014.01.013
878-5409/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reA 12-lead electrocardiogram showed sinus bradycardia alter-
nating with junctional rhythm and ST-segment elevation in leads II,
III, aVF, and V5–V6 (Fig. 1a). He was  medicated with aspirin 250 mg,
clopidogrel 600 mg,  sublingual nitroglycerin 0.5 mg,  and morphine
4 mg,  with minimal symptom relief. Urgent coronary angiography
revealed severe simultaneous two-vessel coronary stenoses: two
stenoses in the circumﬂex artery and three stenoses in the right
coronary artery (Fig. 2, Videos 1 and 2). Intracoronary administra-
tion of nitroglycerin led to a signiﬁcant relief of all coronary lesions
(Fig. 3, Videos 3 and 4), leaving a mild lumen narrowing at the loca-
tion of these lesions. Also, the chest pain and ST segment elevation
resolved (Fig. 1b), thereby establishing the diagnosis of vasospastic
angina.
There was  a non-signiﬁcant elevation of cardiac biomarkers
(maximal troponin I: 0.06 ng/mL). His full blood count and renal
proﬁle were within normal limits. However, he was incidentally
diagnosed with diabetes mellitus and dyslipidemia through labo-
ratory testing.
Echocardiography showed a preserved biventricular systolic
function and no wall motion abnormalities.
Throughout his hospital stay, the patient remained asymp-
tomatic and clinically stable. Continuous electrocardiographic
monitoring did not present any abnormality.
He was  discharged home 5 days later, on a regimen of amlodip-
ine 10 mg  and isosorbide mononitrate 60 mg daily. He was  also
medicated with aspirin, simvastatin, and metformin for cardio-
vascular risk factors (CVRF) control. He was  advised to stop
smoking.
served.
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Fig. 1. Electrocardiogram (ECG) on presentation showing ST elevation over inferior and V5–V6 leads (A) and post-catheterization 12-lead ECG showing resolution of ST-






uFig. 2. Angiographic pictures showing multiple steno
iscussion
revalencePrevalence data of vasospastic angina vary considerably
etween clinical studies, depending in a large part on the geo-
raphic location of the population studied, as well as on the criteria
sed to test and deﬁne the coronary spasm. The CASPAR studyer circumﬂex artery (A) and right coronary artery (B).
reported  an estimated coronary spasm prevalence of 12.5% in ACS
patients [5].
Yasue  et al. [1] suggested that vasospastic angina prevalence
has decreased in Europe and North America, possibly due to the
lower prevalence of smoking and increased use of calcium-channel
blockers.
Vasospastic angina occurs most commonly in middle-aged and
older men  and post-menopausal women, and is signiﬁcantly more





































oFig. 3. Normalized circumﬂex artery (A) and right coronary artery (B) after i
revalent in Japanese than Caucasian patients [1]. Pristipino et al.
6] showed that in the early post-myocardial infarction phase,
apanese patients exhibit a 3-fold greater incidence of vasospastic
esponse to intracoronary acetylcholine than Caucasians. This may
e related to genetic factors and the high prevalence of smoking in
apanese patients [1]. Because of this high vasospastic angina preva-
ence, there was a widespread use of calcium-channel blockers in
apanese patients with hypertension and ischemic heart disease,
hich may  have led to a decrease in vasospastic angina in Japan [7].
athophysiology and etiology
Vasospastic angina usually occurs at rest, particularly at night
nd early morning. It is also often induced by mild exercise, during
arly morning. These circadian variations are possibly due to the
utonomic nervous system and hormonal activities [1].
Several  mechanisms have been proposed for the pathogenesis of
oronary spasm. Oxidative stress-induced endothelial dysfunction
s a main factor involved in the pathogenesis of coronary spasm [1].
hen, all the CVRF that are proved to cause endothelial dysfunction
ay contribute to the occurrence of vasospastic angina. In our case,
here were several CVRF (including not previously diagnosed dia-
etes mellitus and dyslipidemia) that certainly have contributed to
he vasospastic event.
Smoking  is a crucial risk factor for coronary spasm. Other
mportant risk factors and precipitating factors include alcohol
onsumption, cocaine abuse, lipid and glucose metabolism abnor-
alities, magnesium deﬁciency, and genetic factors [8].
cute  coronary syndrome
Coronary  artery spasm is a frequent cause of ACS [5]. The CAS-
AR study showed that 25% of patients presenting with ACS had
o culprit lesion at coronary angiography and nearly 50% of this
roup of patients had coronary spasm documented by intracoro-
ary provocation with acetylcholine [5]. Vasospastic angina should
lways be considered as a differential diagnosis in suggestive pre-
entations of ACS, since this clinical entity has a speciﬁc therapeutic
pproach and generally has a good prognosis [3].
therosclerosis role
Coronary  spasm plays a role in the symptoms of atherosclerotic
oronary artery disease including stable angina, ACS and sudden
ardiac death [1].
Coronary  spasm, which was initially demonstrated in patients
ith normal or near-normal coronary arteries, frequently devel-
ps in sclerotic lesions of varying severity, and is often associatedronary administration of nitrates leading to coronary vasospasm diagnosis.
with  myocardial ischemia and plaque burden [1,9]. Even when no
stenotic lesions are visible on coronary angiography, intravascular
ultrasound (IVUS) reveals clear atherosclerotic lesions in locations
consistent with regions of coronary spasm [9]. Atherosclerotic dis-
ease alters the vasomotor tone and reactivity of the affected vessels,
which may  lead to a particular susceptibility to coronary spasm
events in sites of organic stenosis [1,9]. On the other hand, coro-
nary spasm activates platelets and the coagulation system causing
vascular smooth muscle cell proliferation [1]. Ozaki et al. [2] sup-
ported the hypothesis that persistent coronary spasm can have a
direct role in the process of progression of coronary atherosclerosis
as well, as there is an association between cessation of vasospastic
angina and regression of atherosclerosis.
Angiographic images of the present case show a signiﬁcant relief
of all coronary lesions after intracoronary administration of nitro-
glycerin. However, it is possible to verify coronary irregularities
in the culprit sites of vasospasm, probably representing subjacent
atherosclerotic changes.
Diagnosis
A  deﬁnite diagnosis of vasospastic angina is based on angiogra-
phic demonstration of coronary stenosis during chest pain and/or
electrocardiographic changes that resolve spontaneously or after
intracoronary infusion of nitroglycerin [8]. Alternatively, a provoca-
tive test for coronary spasm can be performed with intracoronary
administration of either ergonovine or acetylcholine [1]. It can also
be performed with a hyperventilation test, which has a relatively
low sensitivity (65%), but a high speciﬁcity (100%) [1].
Multivessel disease and prognosis
Patients who  present with multivessel vasospastic angina more
often have angiographically normal coronary arteries and fre-
quently are resistant to treatment, requiring larger amounts of
anti-ischemic medication to suppress symptoms, which often recur
on cessation of the drugs [1]. These patients are also more likely
to have lethal arrhythmias such as ventricular tachycardia or ven-
tricular ﬁbrillation and are more likely to suffer from sudden death
[1,4]. Thus, we may  consider that our case carries an inherent worse
prognosis due to severe multivessel vasospastic angina.
TreatmentSublingual nitrates can relieve an attack of vasospastic angina.
For the prevention of coronary spasm, treatment with long-acting
calcium-channel blockers is the ﬁrst-line therapy, and additional





















cular  ultrasound detection of atherosclerosis at the site of focal vasospasm in20 I. Rangel et al. / Journal of Ca
1,8]. Additional drugs, such as statins, aspirin, angiotensin-
onverting enzyme inhibitors and angiotensin receptor blockers,
ay be of beneﬁt [1]. Patients with coronary atherosclerosis should
e treated with low doses of aspirin to reduce the risk of cardio-
ascular events. High doses are not recommended since they may
xacerbate coronary spasm by inhibiting the synthesis of prostacy-
lin, a coronary vasodilator [10].
Patients should control all CVRF, particularly smoking, which
ay impair endothelial function. Furthermore, patients should
void excessive alcohol consumption, excessive fatigue, and mental
tress [8].
onclusion
Vasospastic angina should be considered in the presence of
schemia, as it could be reversed with intracoronary nitrates, with-
ut the need for coronary stenting.
Although the prognosis of patients presenting with coronary
asospasm appears to be generally good, multivessel coronary
asospasm may  increase the risk of life-threatening cardiac events.
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